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Abstract
Influenza A viruses, related to high morbidity and mortality worldwide, 
are involved in major pandemics since the 20th century. A new H1N1 
epidemic is happening in Brazil where the Olympics will take place 
late this year. Being a tropical country, the Brazilian climate favours 
the propagation of the viruses. Therefore, other countries need to be 
alert to a possible pandemic dissemination of the viruses due to the 
high flow of people from different countries, and to consider ways of 
stopping such propagation. Methods of prophylaxis currently availa-
ble and in circulation, including vaccine, anti-viral drugs and hygiene 
measures, do not have the desired effectiveness against pandemics. In 
view of the above scenario, it is essential to increase the surveillance 
and intervention on the part of health authorities of all the countries 
in the analysis of potential cases, and to adopt appropriate health 
measures in order to prevent further pandemic outbreaks.
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Vaccine.Influenza A viruses are zoonotic pathogens capable of infecting hu-
man beings, birds, swine, and other mammals. They are responsible 
for recurrent epidemics and occasional pandemics which account for 
up to 5 million serious illnesses per annum and up to 500,000 deaths 
worldwide. [1, 2] These pathogens suffer mutations ranging from spe-
cific ones to large antigenic changes. This in turn brings about new 
viruses, making pandemic outbreaks more likely due to low immunity 
of human beings to the new subtypes brought forth. [3]
Four influenza pandemics have been documented since the begin-
ning of the 20th century. The Spanish flu broke out in 1918, causing 
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the death by H1N1 of about twenty to fifty million 
people worldwide. The origins of the virus have not 
been well established. In 1957, the Asian flu caused 
by the H2N2 subtype, which began in China, was 
responsible for four million deaths, mainly by viral 
pneumonia. In 1968, a pandemic was caused by the 
H3N2 subtype in Hong Kong. Lastly, a pandemic 
influenza caused by H1N1 broke out in Mexico in 
2009 [1, 2, 3].
It is worth noticing that, although the pande-
mics which occurred in the twentieth century had 
in common the emergence of different antigenic 
subtypes of influenza which presented as a product 
of avian influenza, during the year of 2009 a new 
subtype H1N1 was detected, in which swine origin 
virus played a part [4, 5].
In the period from January to April 2016, the 
Ministry of Health of Brazil reported 2,467 cases 
of influenza, with 2,085 positive for subtype H1N1 
and 444 deaths, 411 of these by the same subtype; 
the majority of cases were in the southeast of the 
country [6].
The Zika virus, which affected the Brazilian po-
pulation after major international events, especially 
the World Cup, in 2014 found favorable conditions 
for dissemination through the Aedes Aegypti mos-
quito, quickly became an epidemic, even though it 
was not previously found in this country. Obviously, 
the Influenza A virus can also be spread from this 
country to others, as it is a pandemic virus [7, 8].
Therefore, in the case of a disease with high 
transmissibility and mortality, the strengthening of 
preventive measures must be a global public health 
priority, with vaccination being considered at the 
moment the most effective method. It is estimated 
that in the United States, the vaccine efficacy rate 
is around 59% in adults. Although being the most 
effective, in general terms, during a pandemic, it 
would not provide the same effectiveness, since its 
protection would not be durable and universal [9].
As a result, research is being undertaken to de-
velop vaccines based on the subunits of the protein 
of the virus. This work needs to continue by testing 
through clinical trials, so that these vaccines may be 
licensed for humans because they are more effec-
tive [10].
Another concern, identified in US studies, is that 
although there are programs that promote vacci-
nation in the country, vaccination coverage is com-
promised because of barriers related to beliefs, 
knowledge and attitudes [11].
Another alternative would be the use of neurani-
midase inhibitors, which has produced results that 
are controversial and variable. The meta-analysis of 
observational data of 2009 Influenza A (H1N1) su-
ggests that in hospitalized patients, there is a sig-
nificant reduction of mortality in adults by 25% in 
general, and by 62% if started during 48 hours 
since the onset of symptoms. [12]
Considering the options in dealing with a pan-
demic, it is necessary that the health authorities in 
each country instigate the adoption of educational 
measures of non-pharmacological prophylaxis with 
primary basis of basic hygiene measures, and pro-
mote immunization campaigns through vaccination. 
If a pandemic takes hold, these authorities must act 
in accordance with  World Health Organization gui-
delines, incorporating measures to isolate affected 
patients, adopting quarantine for contacts, travel 
restrictions and social distancing in order to redu-
ce the migration of the virus to people from other 
countries during major events like the Olympics, as 
well as, reducing the probability of mutations bet-
ween influenza subtypes, because Brazil is a tropical 
country with climate favorable to the propagation 
of H1N1. [4]
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